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Retinoic acid is required for the initiation of outgrowth in the
chick limb bud
Thomas Stratford, Claire Horton and Malcolm Maden
Background: Retinoic acid (RA) is present in the chick limb bud, and excess RA
induces limb duplications. Here, we have investigated the role of endogenous
RA during chick limb development by preventing the synthesis of RA and testing
the effect on various genes expressed during limb initiation and outgrowth.
Results: We demonstrate that the stage 20/21 limb bud synthesizes
didehydroretinoic acid (ddRA), and that the posterior half of the limb bud
synthesizes ddRA at a higher rate than the anterior half. Disulphiram inhibits this
synthesis at micromolar concentrations. Administering disulphiram to embryos
prior to limb bud outgrowth (stages 12–18) abolishes outgrowth, and no limb
develops in the majority of cases. Disulphiram treatment also prevents the
expression of Sonic hedgehog (Shh), but the expression of the fibroblast growth
factor-8 gene (Fgf-8) appears as normal in the ectoderm over the prospective
limb bud. The application of a bead soaked in RA can rescue Shh expression.
Disulphiram treatment of later limb buds (stages 20–23) similarly down-regulates
Shh, and also Fgf-4, expression, whereas the expression of Fgf-8, as at earlier
stages, is initially unaffected. Again, RA can rescue the expression of Shh in
these limb buds.
Conclusions: RA, in conjunction with Fgf-8, may be needed for the induction of
the chick limb bud and the induction of Shh and Fgf-4 expression. The
expression of Shh and Fgf-4 remains dependent upon the continued synthesis of
RA within the limb bud. Didehydroretinoic acid is the major active retinoid in the
stage 20 chick limb bud.
Background
Retinoic acid (RA) plays an important morphogenetic role
in several systems of the developing embryo. In the
developing chick limb bud, for instance, the addition of
excess RA has the remarkable ability to organize a new out-
growth from anterior tissue, and the resulting duplicated
limb has a double posterior structure [1]. The subsequent
finding that all-trans-RA is present endogenously in the
chick limb bud at a higher concentration on the posterior
side than the anterior side provided powerful support for
the idea that RA is, in some way, responsible for organizing
pattern in the anteroposterior axis of the limb bud [2]. 
In recent years, however, this simple concept has been
complicated by three further advances in our understand-
ing of limbs. Firstly, in the regenerating amphibian limb,
RA can respecify all three limb axes (proximodistal, antero-
posterior and dorsoventral) [3], rather than just one axis, as
in the chick. Furthermore, complete extra limb fields can
be induced from tail tissue in the frog tadpole [4,5] and
from posterior tissue in the mouse embryo [6]. 
The second advance is that several other retinoic acids, in
addition to all-trans-RA (tRA), have been shown to be
morphogenetically active. These include 9-cis-RA, 4-oxo-
RA and didehydroretinoic acid (ddRA) [7–9]. Although 9-
cis-RA induces duplications of the chick limb bud with a
greater potency than tRA [7], this isomer cannot be
detected endogenously in either chick or mouse limb buds
[10,11], nor in any other part of the mouse embryo (C.H.
and M.M., unpublished data). The wound epidermis of the
regenerating amphibian limb synthesizes 9-cis-RA [12], so
this may reflect a species-specific difference, but this
isomer is unlikely to play a significant part in chick limb
bud development. 4-oxo-RA is present in the Xenopus
embryo [8] but not in the zebrafish embryo [13], and we
know nothing about its presence in higher vertebrate
embryos. On the other hand, the chick limb bud contains
4–6-fold higher concentrations of ddRA compared with tRA
[9,10], and ddRA is equipotent at inducing duplications in
the chick limb bud [9]. Thus, this molecule complicates the
picture as its endogenous concentration would swamp the
endogenous gradient of tRA, and measurements of the con-
centration of ddRA between anterior and posterior parts of
the chick limb bud indicate only a very small excess (1.15-
fold more) in the posterior part [10]. Interestingly, despite
the prevalence of ddRA in the chick limb bud, it cannot be
detected in the mouse limb bud [10], again suggesting
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species-specific differences in retinoid metabolism. Here,
we ask which type of RA is synthesized by the chick limb
bud, and whether the anterior and posterior halves of the
limb bud differ in rates of synthesis.
The third advance is that recent molecular studies of the
developing limb bud have identified an amazing array of
genes involved in limb development — the fibroblast
growth factors (Fgfs) [14–17], Sonic hedgehog (Shh) [18], the
Hoxd complex [19], the Hoxa complex [20,21], Hoxb-8 [22],
the bone morphogenetic proteins (BMPs) [23], the Msx
genes [24], Wnt-7a [25] and Lmx-1 [26]. Analysis of the role
of some of these genes — particularly Fgf-4, which is
expressed in the apical ectodermal ridge (AER) and which
can substitute for the functions of the ridge, Shh, which is
expressed in the region known as the zone of polarizing
activity (ZPA), and Wnt-7a, which is expressed in the dorsal
ectoderm — has suggested that they have a complex recip-
rocal relationship [25,27–29]. RA is generally assumed to be
involved in the induction of limb outgrowth and, by impli-
cation, in the induction of some of these genes, but not in
their maintenance of expression during later development. 
Rigorous testing of these ideas has not been possible,
however, because of the difficulty in depleting embryos of
RA (unlike the readily available ‘knockout’ technology for
the creation of mutants which do not express a particular
gene). Here, we test the role of endogenous RA both in
limb induction and in subsequent outgrowth using disul-
phiram, a compound which inhibits the action of aldehyde
dehydrogenases and, consequently, the synthesis of RA.
Disulphiram prevents the initiation of the chick limb bud
and the appearance of Shh in the posterior mesenchyme,
but not the appearance of Fgf-8 in the AER. Shh expression
can be rescued with RA, demonstrating a role for endoge-
nous RA in the early events of limb initiation. We show that
there is a difference in the rate of synthesis of RA between
anterior and posterior halves of the limb bud, and that
ddRA is the main form of RA synthesized. Furthermore,
during later limb bud outgrowth, similar results are
obtained: Shh expression and Fgf-4 expression in the AER
both depend upon the synthesis of RA in the limb bud,
whereas Fgf-8 does not become down-regulated immedi-
ately. These results demonstrate a continuing role for RA in
limb development, in addition to its role in limb initiation.
Results
Synthesis of RA by chick limb buds
We first asked which type of retinoic acid was synthesized
from [3H]all-trans-retinol in the chick limb bud. A two-
column high-pressure liquid chromatography (HPLC)
procedure was used to identify which [3H]RA isomers
were generated after incubating stage 20/21 limb buds
with [3H]all-trans-retinol. (We have recently developed
and used this method to demonstrate that the wound epi-
dermis of the regenerating newt limb synthesizes 9-cis-RA
[12].) After incubating 50–80 limb buds in 500 nM
[3H]retinol for 5 hours, extracts were fractionated on a
normal-phase LiChrospher NH2 column, and the acid
metabolites collected (Fig. 1a) [30]. This column retains
only the acids and discards excess unmetabolized
[3H]retinol, which obscures other retinoid peaks on a
reverse-phase chromatograph. This acid peak was then re-
run on a C18 reverse-phase column, which can separate
different retinoic acids, revealing that the label was in a
peak corresponding to ddRA (Fig. 1b). Thus, it seems that
the chick limb bud metabolizes all-trans-retinol primarily
to ddRA, and not to all-trans-RA (tRA) as might be
expected. Other retinoic acids, including tRA, may be
generated but, if so, they were at undetectable levels —
any peak 5–10-fold lower than the ddRA peak would not
have been detected. 
These observations are consistent with previous data
from the chick: the endogenous concentration of ddRA is
5–6-fold higher than that of tRA; chick tissue contains
the enzymes required for the synthesis of ddRA from
retinol; and there is no significant conversion of ddRA to
tRA [9]. Furthermore, the results are not artefacts of the
method as, using the same techniques, we have found
that the newt wound epidermis generates 9-cis-RA [12]
and mouse embryonic tissue generates all-trans-RA
(M.M. and C.H., unpublished data). That different
organisms generate different retinoic acids may have
mechanistic significance for the differential activation of
receptor pathways.
Differential synthesis of ddRA by anterior and posterior
halves of the chick limb bud
The observation of the synthesis of ddRA by the limb bud
raises the question of the significance of the differential
distribution of tRA between anterior and posterior por-
tions of the limb bud [2], as this must now be relegated to
being only a minor component of the retinoid profile of
the limb bud. To examine whether differences in the syn-
thesis of ddRA could be detected between anterior and
posterior halves of limb bud, we cut 150–200 stage 20/21
buds into two halves and repeated the incubations with
[3H]retinol followed by chromatography.
The results of three repeats of this experiment showed that
there was a small, but reproducibly higher rate of synthesis
of ddRA by posterior halves compared with anterior halves
of the limb bud (Table 1). These data are supported by the
small difference in endogenous concentration of ddRA
between anterior and posterior halves of the chick limb bud
[10] and by similar measurements that have been made
using the F9 reporter cell system (M.M., unpublished data).
Inhibition of synthesis by disulphiram
Disulphiram is a compound which inhibits the action of
aldehyde dehydrogenase enzymes [31] and, consequently,
inhibits the synthesis of RA in embryonic systems [32,33].
When limb buds were incubated with [3H]retinol, in the
presence of 1–10 mM disulphiram, the synthesis of acid
metabolites was completely inhibited (Fig. 1c). This was a
dose-dependent phenomenon that showed a cut-off point
between 10–5 M and 10–6 M. This concentration is the
same as that at which disulphiram inhibits the synthesis of
RA from retinaldehyde in the chick, mouse and rat retina
(6–50 mM) [32,33]. 
The effect of disulphiram on early limb development
Disulphiram could therefore now be used to examine the
effect of inhibiting RA synthesis on limb development. In
the first series of experiments, disulphiram was
incorporated into Silastic Medical Elastomer, a compound
which can be used as a slow release depot [34]. A
250 × 250 × 500 mm block of disulphiram-impregnated
silastin (25–100 mg ml–1) was then placed adjacent to the
flank of pre-limb bud or early limb bud (stages 15–18) and
the limbs observed at daily intervals.
This treatment resulted in three different outcomes. In
the majority of cases (76 %, n = 43; Table 2, row 1), no
limb developed on the treated side (Fig. 2a,d,e) or a small
protrusion appeared on the flank in the region of the pos-
terior part of the limb bud, presumably in an attempt to
initiate development (Fig. 2c). Sections through these
embryos confirmed the lack of any recognizable limb out-
growth (Fig. 2d). When these embryos were incubated
until good cartilage differentiation had occurred in the
contralateral limb, all that was present on the treated side
was a scapula and sometimes part of a humerus as well
(Fig. 2e). In such inhibited limbs, the shoulder girdle
always formed.
The remaining 24 % of cases had normal limbs or displaced
limbs. We attribute the small number of normal limbs to a
failure of the experiment — the block of silastin had been
displaced during incubation, and so these embryos never
received any treatment. We attribute displaced limbs to
either a recovery from the effect of disulphiram or a partial
displacement of the silastin block such that the dose
received was less than intended. These displaced limbs, as
Figure 1
HPLC chromatograms showing the synthesis of ddRA from retinol by
chick limb buds and its inhibition by disulphiram. (a) NH2 column
chromatograph of limb-bud extracts incubated with [3H]all-trans-retinol.
This column retains acids, separating synthesized [3H]RAs from the
added retinol. The dotted line shows the radioactivity (scale on the
right) with a large peak in the void volume (unmetabolized [3H]retinol)
and a peak at 19.5 min, which is the retained [3H]RA. This has been
generated from the added retinol, as control incubations without any
tissue does not give a RA peak. The solid line is the UV absorbance of
cold RA which was added to the extract, thereby confirming the
identity of the radioactive peak. (b) When the fractions from the NH2
column are collected and re-run on a C18 reverse phase column, the
identity of the [3H]RA isomer can be deduced. The solid line shows the
UV absorbance of 5 cold standards which are run along with the
radioactive sample: 1 = ddRA, 2 = 13-cis-RA, 3 = 11-cis-RA, 4 = 9-
cis-RA, 5 = all-trans-RA. The dotted line is the radioactive fractions
from the NH2 column, which coelute with ddRA. The radioactive peak
at 2.5 min is a highly polar RA metabolite which elutes in the void
volume; it is not any known polar metabolite, such as 4-oxo-RA, which
elutes at 7.5 min. (c) Limb buds incubated with 10–6 M disulphiram
and the extract run on a NH2 column. In this case, the synthesis of
retinoic acid is completely inhibited and the only radioactive peak
(dotted line) is the unmetabolized [3H]retinol in the void volume. Solid
line marks the UV absorbance of a cold RA standard.
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shown in Figure 2b, were always displaced posteriorly,
never anteriorly, and by as much as a four-somite distance.
When these limbs were incubated until good cartilage dif-
ferentiation had occurred, the displacement became
obvious and the limbs were always deficient in cartilage
structure (Fig. 2f). However, these limbs all had the appro-
priate anteroposterior polarity, even though they were dis-
placed posteriorly, unlike the situation where an extra limb
is induced posteriorly to the normal one — in which case
the anteroposterior polarity of the induced limb is reversed.
Two other methods used to administer disulphiram
produced identical results to the disulphiram-impregnated
silastin treatment. One method involved soaking a piece
of newsprint in disulphiram solutions, and the other
involved injecting the lipophilic dye DiI and disulphiram
into the appropriate position in the flank of the embryo.
Summing all the data with three different methods of
disulphiram administration gives a total of 70 % inhibition
of limb outgrowth (n = 81) at these early stages. Control
treatments using silastin blocks, dimethylsulphoxide
(DMSO)-soaked paper or injections of DMSO and DiI
had no effect on limb development.
Although a complete dose-response experiment has not
been performed, it was observed that far fewer limbs were
affected by a dose of disulphiram below 10 mg ml–1. The
dose of disulphiram administered in vivo (100 mM) is con-
siderably higher than that required to inhibit RA synthesis
in vitro (10–100 mm). We attribute this to the fact that the
embryos were treated with disulphiram externally, which
would result in only a very small proportion of the dose
being taken up into the tissues or, when injected, a very
small area of the flank being treated. Three observations
Figure 2
The effect of disulphiram on chick limb
development. (a) A block of silastin
impregnated with disulphiram (100 mg ml–1)
was placed next to the right flank of a stage
15 embryo. After 48 h, the left limb bud has
appeared normally, but the right limb bud is
completely absent. (b) A similar treatment to
(a) has, in this case, resulted in a smaller limb
bud on the right side which has shifted
posteriorly by about 4 somites. (c) A similar
treatment to (a) has, in this case, resulted in
only a pimple of tissue appearing in the
posterior region of the location of the limb bud
(arrow). (d) Transverse section through an
embryo showing a normal limb bud on the
right side of the section and the complete
absence of a limb on the disulphiram-treated
left side of the section. Also present in these
sections is an abnormal notochord
(arrowhead), which has become zig-zagged in
the region of disulphiram treatment. This is the
same phenomenon that is seen in zebrafish
embryos [13]. (e) Victoria blue-stained 9 day
embryo, which had been grown up from a
group shown in (a). The control (left) limb has
a normal cartilage pattern, whereas the
disulphiram-treated (right) limb only has the
shoulder girdle. The limb is completely
missing on this side (arrowhead). (f) Victoria
blue stained 9 day embryo which had been
grown up from a group shown in (b). The
control (left) limb has a normal cartilage
pattern, whereas the disulphiram-treated
(right) limb has been shifted posteriorly by a
distance of about 3–4 vertebrae. The limb
itself is very deficient, the humerus is stunted,
the radius is missing and the ulna is stunted.
Table 1
Rates of synthesis of ddRA (in cpm per mg tissue) of anterior
and posterior halves of stage 20/21 chick limb buds.
Experiment
1 2 3
Anterior 73 87 140
Posterior 101 116 173
A:P ratio 1:1.4 1:1.33 1:1.24
Table 2
Effects of disulphiram treatment on stage 15–18 chick
embryos.
Dose of Number of Inhibition of limb Absence of Shh
disulphiram cases initiation/outgrowth expression
(mg ml–1) 24 h 36 h 48 h
100 43 33 (76%) – – –
25 5 3 (60%) – – 3
10 6 4 (67%) – 4 –
10–25 12 9 (75%) 9 – –
argue against a simple toxic effect of disulphiram despite
the relatively high doses administered: the limbs could be
rescued with RA (see below); Fgf-8 continued to be
expressed in the AER (see below); and the effects on gene
expression could be reproduced in culture at doses of
10–100 mM (data not shown).
Effect of disulphiram on gene expression at early stages
We analyzed the effect of disulphiram on two genes
expressed in the early limb bud, Shh and Fgf-8. Shh is
expressed in the mesenchyme of the posterior margin of
the limb from stage 17 [18]; by this stage, limb outgrowth
is clearly visible. As ectopic Shh is inducible by RA [18],
we wished to ask whether endogenous Shh is responsive to
RA synthesis. Fgf-8 is expressed in the ectoderm over the
prospective limb bud at stage 16, and is thought to play a
role in the initiation of limb outgrowth [17]. The range of
stages (15–18) at which disulphiram treatment was
performed initially was the same as in the previous experi-
ment, and encompassed the period over which Shh and
Fgf-8 begin to be expressed in limb tissue. 
Treatment with disulphiram prevented Shh expression in
the area of the missing limb when examined 24 hours later
(Fig. 3a; Table 2, row 4), 36 hours later (Table 2, row 3) or
48 hours later (Table 2, row 2). In the minority of cases
which showed good limb outgrowth, Shh expression was
normal. The frequency of loss of Shh expression in these
experiments (69 %, n = 23) was the same as the frequency
of loss of limbs (70 %, n = 81) in earlier experiments. The
earliest time period at which an effect of disulphiram on
expression of Shh was observed was 17 hours (data not
shown), so Shh does not respond rapidly to the inhibition
of RA synthesis.  At the other extreme, as the frequency of
loss of Shh expression at 48 hours was the same as at earlier
time periods, we presume that limb buds cannot recover
from an early loss of Shh, nor regenerate Shh expression.
In contrast, Fgf-8 expression appeared normal in the
ectoderm over the initiating limb in the absence of RA
synthesis and Shh expression, as shown by double in situ
hybridization experiments (Fig. 3c,d). The absence of Shh
expression in these Fgf-8-positive limb buds confirmed
that the disulphiram treatment had been effective. In
order to ensure that we had treated embryos considerably
before the onset of Fgf-8 expression in the ectoderm of the
limb field, we performed additional experiments treating
as early as stage 12, and examined the embryos by double
in situ hybridization 24 hours later. In this case, 8 out of 17
limbs (47 %) showed Fgf-8 expression in the absence of
Shh expression. The remaining cases showed expression of
both genes with good limb outgrowth, and were presum-
ably failed experiments. At longer time periods after treat-
ment (36 hours), we observed continued expression of
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Figure 3
Shh and Fgf-8 expression in disulphiram-
treated early limb buds. (a) Shh expression in
an embryo which had been injected with
disulphiram (50 mg ml–1) 24 h earlier into the
flank at stage 16 on the right side. On this
side, the limb bud has not developed and
there is no Shh expression, whereas the
control (left) side shows typical Shh
expression in the ZPA. (b) A disulphiram-
treated early embryo (stages 15–18), which
was rescued by implanting a RA-soaked
bead opposite somite 20 (arrowhead). In
contrast to disulphiram treatment, which
prevents outgrowth of the limb and Shh
expression, the addition of RA has allowed
the limb to grow out and express Shh. (c,d)
Double in situ hybridization with Shh and Fgf-
8 in a stage 18 embryo. (c) The normal left
limb shows Shh expression on the posterior
margin (arrow) and Fgf-8 in the AER. (d) The
right limb had been treated 24 h earlier (at
stage 15) with disulphiram and, despite
showing no Shh expression, still shows Fgf-8
expression even though no limb outgrowth is
visible. (e,f) Expression of Fgf-8 in a stage 22
embryo. (e) The normal left limb shows Fgf-8
expression in the AER and Shh expression in
the ZPA (arrow). (f) The right limb had been
treated 36 h earlier (at stage 15) with
disulphiram and shows only a very small
amount of outgrowth despite the continued
expression of Fgf-8.
Fgf-8 despite the severe inhibition of limb outgrowth (Fig.
3e,f). After 36 hours, Fgf-8 expression began to decline.
Rescue of limb outgrowth by RA
If the effect of disulphiram in vivo is to inhibit RA
synthesis (along with other aldehyde dehydrogenases),
resulting in the failure to induce limb outgrowth, then the
provision of additional RA should restore limb outgrowth.
If, however, its effect is toxic, killing cells, then no such
rescue would be expected (although the initial lack of
effect on Fgf-8 expression already argues against this con-
tention). To distinguish between these two alternatives,
we treated embryos at the same stages (stages 15–18) with
disulphiram and RA simultaneously. Beads soaked in RA
(at concentrations of 100 mg ml–1 to 1 mg ml–1) were
placed opposite somite 20, and the flank of the same side
of the embryo was treated with disulphiram. Rescue was
assayed by the presence of a high level of expression of
Shh and by obvious outgrowth. After 24 hours, 75 % of
embryos showed a high level of Shh expression (n = 8; Fig.
3b), and after 36 hours, 60 % showed a high level of Shh
expression (n = 5). Thus, 64 % of disulphiram-treated limb
buds expressed Shh at high levels after rescue by RA. Fur-
thermore, most of the remaining limbs showed some
rescue of outgrowth and low Shh expression. In the initial
experiments, disulphiram alone abolished Shh expression
in 69 % of embryos (Table 2; thus 31 % showed some Shh
expression); in these rescue experiments, 64 % of limbs
expressed high levels of Shh. Hence, the addition of RA
more than doubled the number of disulphiram-treated
limb buds in which Shh was expressed.
Effect of disulphiram on gene expression at later stages
To determine whether inhibition of RA synthesis has any
effect on gene expression in limb buds that have become
established, limb buds at stages 20–23 were treated with
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Figure 4
Shh, Fgf-4 and Fgf-8 expression in
disulphiram-treated late limb buds. (a,b) Shh
expression in an embryo whose right limb bud
(b) had been injected with disulphiram
(50 mg ml–1) 24 h earlier at stage 20. There is
no Shh expression in this limb. The left control
limb, shown in (a), has normal Shh expression.
(c,d) A similar embryo to that shown in (a,b),
except that, in this case, a small and weakly
expressing region of Shh has remained in the
disulphiram-injected right limb (d). Normal
expression is present in the control left limb
(c). (e,f) Double in situ hybridization
experiment with Fgf-4 (in the AER;
arrowheads) and Shh in a control limb (e) and
a disulphiram-treated limb (f). In the
disulphiram-treated limb, neither gene is
expressed, in contrast to the control. (g,h)
Double in situ hybridizations with Fgf-8 (in the
AER; arrowheads) and Shh in a disulphiram-
treated limb (g) and a control limb (h). In the
disulphiram-treated limb, Shh is absent but
Fgf-8, although weaker, has continued to be
expressed in the AER. (i,j) Late rescued limbs.
(i) A control limb, 48 h after stage 20–22, has
reached stage 28 and Shh expression is
much reduced on the posterior margin. (j) In
contrast, a disulphiram-treated limb with an
RA-soaked bead placed posteriorly (arrow)
has resulted in the rescue and continued
strong expression of Shh. (k) A stage 20
disulphiram-treated limb 30 h after an RA
bead (white arrow) was placed anteriorly. The
normal expression of Shh on the posterior
margin has disappeared, and a new domain of
Shh expression is beginning to appear on the
anterior side (arrowhead). (l) The cartilage
pattern in a limb which had been treated with
disulphiram at stage 20–22 and incubated for
7 days (on the left) compared with its normal
counterpart (on the right). Despite the loss of
Shh and Fgf-4 expression following
administration of disulphiram, as shown in
panels (a–h), the anteroposterior patterning of
the limb on the left is perfectly normal
although the proximodistal length of the
elements is reduced (see text for details).
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disulphiram. The expression of Shh and Fgf-8 was
examined as in the previous section, together with Fgf-4,
which is thought to be involved in a feedback loop with
Shh and Wnt-7a [25,27–29]. 24 hours after treatment, the
expression of Shh was either switched off (Fig. 4a,b) or
severely down-regulated (Fig. 4c,d) in 48 % of limbs
(n = 60; Table 3). Similar results were also seen 30 hours
(38 % inhibition, n = 13) and 36 hours (38 % inhibition,
n = 8) after treatment. Treated limb buds were then exam-
ined for the expression of both Shh and Fgf-4, or Shh and
Fgf-8, by double in situ hybridization. The results revealed
that, in those limb buds where Shh was down-regulated, so
also was Fgf-4 expression in the AER (Fig. 4e,f). We
interpret these results as confirmation of the feedback
loop which is proposed to operate between these two
genes [27,28]. In contrast, Fgf-8 expression was main-
tained in the AER, although at somewhat reduced levels
(Fig. 4g,h). This demonstrates that, as at earlier stages,
Fgf-8 expression is not immediately responsive to the
absence of RA synthesis.
The majority of limb buds treated with disulphiram at
these later stages, when observed externally, seemed rela-
tively normal. However, 47 % (n = 64; Table 3, row 2)
were observed to show either a slight distal thinning of the
limbs or a reduction in the length of the proximodistal axis
when compared with the contralateral control limb bud. A
group of these limbs (n = 29) were incubated for a total of
10 days to examine the size of the cartilage elements
(Table 3, row 3). All these limbs had normal anteroposte-
rior polarity, although 30 % showed slight reductions in
the length of both the humerus (range 0–17 %) and the
radius (range 5–25 %) (Fig. 4l). Control treated limbs
showed no reduction in Shh expression, no change in
external shape and normal cartilage patterning at 7–10
days of incubation.
Rescue of later limb buds by RA
In order to demonstrate that the action of disulphiram on
gene expression at later stages was not due to toxicity, we
performed rescue experiments of disulphiram-treated
limbs (stage 20–22), using RA beads (soaked in 100 mg ml–1
to 1 mg ml–1 disulphiram) placed under the AER at the
posterior margin. This treatment resulted in high levels of
expression of Shh 24 hours (78 %, n = 14), 32 hours (100 %,
n = 2) and 36 hours (80 %, n = 5; Fig. 4i,j)  after treatment.
Without rescue, 52 % of limbs showed strong Shh expres-
sion whereas, with added RA, this frequency increased to
81 %. Control beads soaked in DMSO and placed on the
posterior margin of disulphiram treated limb buds did not
rescue Shh expression. 
Finally, we performed induction experiments by implant-
ing a RA bead on the anterior margin of a disulphiram-
treated limb rather than the posterior location as above. In
3 out of 12 cases, this treatment resulted in the disappear-
ance of endogenous Shh on the posterior side (caused by
disulphiram) and the appearance of Shh on the anterior
side (caused by RA) (Fig. 4k). 
Discussion
RA synthesis in the chick limb bud
We have shown that the stage 20/21 chick limb bud
synthesizes primarily didehydroretinoic acid from [3H]all-
trans-retinol in our assay system. In other experiments
using the same procedures, we have found that the newt
wound epithelium generates 9-cis-RA [12] and that the
mouse embryo generates all-trans-RA. This suggests that
the form of RA generated in embryos is species-specific,
which may have consequences for the differential activa-
tion of specific receptor pathways. The retinoic-acid
receptors (RARs) are activated by ddRA and tRA, but the
other class of retinoic-acid receptors, the RXRs, are acti-
vated by 9-cis-RA [35]. Thus, in the absence of any
detectable 9-cis-RA in the chick and mouse embryo, it is
possible that RXRs are not activated by ligand and behave
as silent partners. In the amphibian limb, however, where
9-cis-RA is the predominant retinoid synthesized, RXRs
would be readily activated. 
Although the endogenous concentration of ddRA in the
chick limb bud is 4–6-fold higher than that of tRA [9,10]
and we found ddRA to be the major metabolite, these two
retinoic acids have identical abilities in activating the
RARs [35]. Thus, these findings do not have any signifi-
cance for receptor studies in the chick limb bud. We also
demonstrated that the rate of synthesis of ddRA varied
between the anterior and posterior half of the limb bud,
with the posterior half showing a consistently higher rate
than the anterior half. These data support the demonstra-
tion of a higher endogenous concentration of ddRA in the
posterior half of the chick limb bud [10].
We showed here that disulphiram, an inhibitor of alde-
hyde dehydrogenases [31], inhibits the synthesis of
retinoic acid and that this compound can be used (and has
been used [32,33]) to ask questions about the role of
endogenous RA in various embryonic systems. Of course,
Table 3
Effects of disulphiram treatment on stage 20–23 chick limb
buds.
Dose of Number of Reduction in Change in Normal
disulphiram cases Shh expression shape of cartilage
(mg ml–1) at 24 h limb bud pattern
(24–48 h) (7–10 days)
10–100 60 29 (48%) – –
10–100 64 – 30 (47%) –
10–100 29 – – 29 (100 %)
other aldehyde dehydrogenases will be inhibited at the
same time as there is no suggestion that disulphiram is
specific for retinaldehyde dehydrogenase, but by perform-
ing rescue experiments we were able to demonstrate that
it is the loss of RA itself which results in the failure of limb
outgrowth and the down-regulation of certain genes.
RA and limb induction
The treatment of embryos with disulphiram before the
limb bud appears prevents limb development in the
majority of cases (70 %, n = 81). After 24 hours, a small
pimple of tissue can be detected which does not express
the gene Shh. By contrast, the expression of Fgf-8, which is
present in the ectoderm over the prospective limb area, is
normal in treated embryos, and continues to be expressed
in inhibited limbs which fail to grow out. Eventually, Fgf-8
seems to disappear. That this effect of disulphiram is
related to RA and not to a toxic effect on cells was demon-
strated by the ability of added RA to rescue Shh expression
in disulphiram-treated embryos. It is likely, therefore, that
Fgf-8 and RA are both required for chick limb bud initia-
tion, and that Shh expression is induced either by RA
alone or by RA and Fgf-8. Thus, the induction of limb out-
growth by various FGFs [17,36] should only occur in
regions of the embryo which can also synthesize RA.
Interestingly, some of these disulphiram-treated embryos
did produce limbs, but these limbs were often displaced
posteriorly, perhaps in an attempt to ‘regenerate’. As the
limb field encompasses a larger area that the tissue from
which the normal limb actually arises, and limb induction
can occur posterior to the normal limb [17,36], this posterior
displacement may not be surprising. However, in contrast to
the induced extra limbs, these displaced limbs had a normal
anteroposterior polarity with respect to the body axis.
RA and later limb outgrowth
After the limb bud has begun development, disulphiram
had no dramatic effect on final limb morphology. This
striking difference in result between treating at stages
prior to limb bud outgrowth compared with treating at
stages after limb bud outgrowth is precisely the same as
the effects of retinoid receptor antagonists on limb devel-
opment [37]. Only minor abnormalities in limb structure
were observed, such as proximodistally shorter elements,
and the limbs were normal in the anteroposterior axis.
Gene expression was affected in the same way as in the
study on earlier stages, although in a smaller number of
cases, and we also examined the effect on Fgf-4. Shh and
Fgf-4 were both completely down-regulated by 24 hours,
but Fgf-8 only showed a slight decrease in expression
level. Again, the fact that the effect of disulphiram was not
due to toxicity was demonstrated by adding back RA and
reinitiating the expression of Shh. We could also reinitiate
Shh expression on the anterior side of the limb bud having
eliminated it on the posterior side (Fig. 4k).
We have not established whether both Shh and Fgf-4, or
just one of these genes, are directly affected by levels of
RA. Removal of the AER down-regulates Shh [29], so the
down-regulation of Fgf-4 by lack of RA synthesis would
also result in the absence of Shh expression. Similarly,
ectopic Shh expression induces an expanded Fgf-4 domain
[28], so if RA levels primarily control Shh expression,
down-regulation of Shh will affect Fgf-4 as well. As RA and
Fgf-4 act together to induce Shh [29], and neither will
suffice alone, it is most likely that the lack of RA has its
effect by interacting with both gene pathways. In reality,
it is far too soon to speculate on the pathway(s) of RA
action, as the other genes known to be involved in limb
development (such as Wnt-7a, Lmx-1, the BMPs and the
various Hox genes) need to be examined for the effect of
disulphiram on their expression patterns.
In these experiments on later stage limb buds, the lack of
major morphological effect, which has also been seen
when treating limb buds with retinoid receptor antagonists
[37], is in contrast to the effects on earlier stages. This may
be due to one of several factors: the delay in the drug
taking effect; the retention of some Shh-expressing cells
(less than 100 ZPA cells are required for Shh to exert its
function [38]); or the regeneration of Shh-expressing cells.
However, we note that experiments involving the physical
removal of the ZPA (Shh-expressing cells) after stage 20
revealed a similar lack of effect on the proximodistal or
anteroposterior axes [39]. Also, the limb buds of the limb
deformity (ld) mouse mutant fail to express Fgf-4, and the
expression of Shh is considerably reduced, even though the
limb abnormality is relatively minor — syndactyly and
oligodactyly [40].
Developing chick limbs and regenerating amphibian
limbs
These results bring studies on the role of RA in the
chick limb bud and the regenerating amphibian limb
much closer together. Emphasis in the chick experi-
ments has always been on the role of RA in patterning
across one axis, the anteroposterior axis. In the regener-
ating amphibian limb, where all three limb axes are
affected [3], and in the regenerating amphibian tail,
where RA transforms a tail blastema into legs [4,5],
emphasis has been placed on the role of RA in the initia-
tion of limb outgrowth — the establishment of the limb
field [41]. The experiments described above suggest
that, in the chick limb bud, RA is involved in limb
induction, together with the FGFs. Clearly, it is now of
interest to examine the effect of inhibiting RA synthesis
with disulphiram on the expression of the multitude of
other genes which are expressed in the developing limb
bud. This compound provides us with a valuable tool to
examine the role of RA, not only in the limb bud, but
also in other embryonic systems where RA is thought to
play a part.
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Materials and methods
Chick embryos
Fertile eggs were obtained from Needle Farms, Enfield and incubated
and staged according to Hamburger and Hamilton [42]. Eggs were
windowed and treated with disulphiram (Sigma) by several methods. In
one method, disulphiram powder was mixed with Silastic Medical Elas-
tomer (Dow Corning) and the solidified mixture was cut up into small
pieces (250 mm cubes). The cubes were placed adjacent to the flank
on one side of the embryo at early stages (12–18) or underneath the
limb bud at later stages (20–23). In another method, disulphiram was
dissolved in DMSO and pieces of blotting paper were immersed in the
solution. Fragments of these pieces were then pinned to the flank of
the embryo above the limb bud or limb forming region. In another
method, disulphiram was dissolved in dimethylformamide into which DiI
had been dissolved and the mixture then injected into the posterior
region of the limb bud. After varying time periods following treatment,
embryos were fixed either for in situ hybridization or for cartilage
staining with Victoria blue.
RA synthesis
50–80 stage 20/21 limb buds were incubated for 5 h in 1 ml of DMEM
(Gibco) plus 500 nM [3H]all-trans-retinol with various additives
(NaHCO3, penicillin/streptomycin, glutamine, BSA, transferrin,
putrescine, sodium selenate, T3, insulin, progesterone, corticosterone)
at 37 oC, 5 % CO2. The same culture conditions were used for anterior
versus posterior half limb buds, where 150–200 limb buds were cut
into two halves.
HPLC
Retinoids were extracted from the limb buds (the supernatant was
discarded) as described previously [2] with minor modifications. After
sonication in 0.5 ml stabilizing buffer, 20 ml aliquots were removed for
protein analysis and 200 ng each of the appropriate synthetic
standards were added prior to extraction with two volumes of extrac-
tion solvent. The solvent phases were pooled after separation by low-
speed microcentrifugation, dried under nitrogen, resuspended in
100 ml methanol, centrifuged at high speed and transferred to HPLC
autosampler vials. HPLC was performed using a Beckman System
Gold Hardware with a UV detector (351 nm) in series with a solid
scintillant radioisotope detector. For normal phase chromatography,
the method was according to [30], with modifications as follows:
50 ml of extract was autoinjected onto a 5 mm LiChrospher 100 NH2
column (Merck) with an equivalent pre-column and eluted at
1ml min–1, for 5 min initially, with 100 % mobile phase C (chloroform:
methanol, 9:1) changing over 1 min to 100 % mobile phase D (chloro-
form: methanol: acetic acid, 9.0:0.9:0.1) for a further 20 min. The
eluant was monitored both with a UV detector at 351nm and for
radioactivity. The fractions corresponding to the RA peak were
pooled, dried down resuspended in 100ml methanol and re-analyzed
by reverse phase chromatography. For reverse-phase chromatogra-
phy, the pooled peak fractions were autoinjected onto a 5 mm
encapped C18 LiChrospher 100 column (Merck) with an equivalent
pre-column and eluted at 1 ml min–1 under gradient conditions as
follows: 40 % mobile phase A (1 % acetic acid), 60 % mobile phase B
(acetonitrile: methanol, 3:1) rising linearly to 100 % mobile phase B
over 25 min. The eluant was monitored as above.
In situ hybridization
These experiments were performed with Shh, Fgf-4 and Fgf-8 probes
according to standard protocols.
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